| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Department of Psychology, Brigham Young University, Provo, Utah.
Address correspondence and reprint requests to Julianne Holt-Lunstad, Department of Psychology, Brigham Young University, Provo, UT 84602-5543. E-mail: julianne_holt-lunstad{at}byu.edu
| ABSTRACT |
|---|
|
|
|---|
Methods: In this study, 302 healthy adults (51% female; average age 31 years) underwent 24-hour ambulatory BP assessment with BP measured randomly approximately every 20 minutes during waking hours and every hour during sleep. Salivary cortisol was obtained at five time points. Cortisol and BP have natural diurnal variations and disruptions in these diurnal variations are related to pathological conditions, such as greater risk for cardiovascular disease. A lack of a drop in cortisol from day to night and a lack of a drop in BP from waking to sleeping have both been associated with negative outcomes. It is not known, however, if diurnal variations in cortisol and BP are related, or if changes in cortisol from day to night influence BP dipping.
Results: Diurnal cortisol variation was a significant predictor of BP dipping. Controlling for gender, body mass index, age, phase of menstrual cycle, sleep quality, morning cortisol, and daytime measures of the relevant cardiovascular assessments did not significantly affect the results. Cortisol variation was found to have a stronger relationship with BP dipping than any of the covariates measured.
Conclusion: Decreased diurnal variation in cortisol is associated with decreased diurnal variation in BP. Future studies could benefit from examining how these two variables interact in predicting disease outcomes.
Key Words: ambulatory blood pressure cortisol circadian rhythm cardiovascular functioning health
Abbreviations: BP = blood pressure; SBP = systolic blood pressure; DBP = diastolic blood pressure; SES = socioeconomic status; HPA = hypothalamic-pituitary adrenalcortical; BMI = body mass index; AUC = area under the curve.
| INTRODUCTION |
|---|
|
|
|---|
The BP circadian rhythm is typically characterized by minor fluctuations throughout the day and night, with an overall decrease (or dipping) that occurs during the night. Normotensive patients with mild-to-moderate hypertension typically show a 15% to 20% reduction in BP during sleep. However, a lack of nocturnal BP dipping may occur and is more prevalent among those with various disease states (e.g., hypertension, sodium sensitivity, chronic renal failure, sleep apnea, Cushings syndrome, and autonomic nervous system dysfunction) (10). Although disrupted BP rhythms have primarily been examined among nonnormal samples, a lack of dipping also occurs among normal individuals and factors, such as stress and socioeconomic status (SES), have been implicated in the cause. Research has demonstrated that chronically stressed individuals also show altered BP rhythms (11,12).
Importantly, disruptions in normal patterns of cortisol and BP have both been linked to negative health outcomes. For instance, the effect of cortisol disruption has been linked to immunosuppression, metabolic problems, Addisons disease, Cushings disease, and even increased mortality. For example, flattened cortisol slope (lack of normal diurnal variation) predicted earlier mortality 7 years later among patients with metastatic breast cancer (13). A lack in BP dipping has also been associated with increased health risks including left ventricular hypertrophy (14,15), kidney damage (16), cerebrovascular stroke (17), cardiovascular morbidity (18), and even increased mortality (19,20). Thus, a disrupted circadian rhythm may have important long-term health implications.
Although a large research literature examines hypothalamic-pituitary adrenalcortical (HPA) and sympathetic function, it is not well understood the extent to which these distinct physiological systems may influence each other thereby placing additional strain on the organism. Most studies examining cortisol and BP rhythms tend to look at them in isolation, which obscures potential links. The few studies that do support an association between cortisol and BP (21–23) are limited by small sample sizes and diseased populations or they fail to examine their circadian rhythms. Therefore, the primary aim of this study was to directly examine this potential link. Given that cortisol and BP are both related to stress and that elevated evening cortisol is related to increased arousal and disrupted sleep (13,24), it was hypothesized that a lack of a drop in cortisol from day to night would be associated with decreased BP dipping. As an ancillary aim, we were also interested in examining the relative importance of age and normotensive versus prehypertensive status in moderating such an association.
| METHOD |
|---|
|
|
|---|
Procedures
Subjects volunteered to participate in a 24-hour study in which ambulatory BP was monitored and salivary cortisol was obtained. The data were collected over 1.5-year period between 2003 and 2005 and were approved by the Institutional Review Board/Ethics Committee at Brigham Young University. Interested participants were first screened over the phone to determine if they met the inclusion criteria. Qualified participants were scheduled to come into the laboratory on week days (Monday through Friday) to standardize the impact of a work day versus nonwork day. At the laboratory (after consent was obtained), participants completed a packet of questionnaires that assessed standard variables that may influence health (e.g., demographics, health history). Height and weight were obtained on a standard medical scale (e.g., Health-O-Meter) to ensure accurate measurements of body mass index (BMI). Three baseline clinical BP measurements were taken using a sphygmomanometer and stethoscope. Participants were then given instructions for ambulatory monitoring and a trained research assistant placed the monitors on the subjects. For validation purposes, a minimum of three readings from the ambulatory monitor were compared against those readings obtained from a sphygmomanometer using a T-tube adapter. Readings were considered valid if three consecutive readings matched (±5 mm Hg). After the BP validation procedure, participants received verbal and written instructions on saliva collection. A saliva sample was taken to ensure they knew how to properly collect the saliva and to obtain a morning sample. Each participant was asked to collect saliva four additional times during the next 24 hours. Thus, a total of five salivary cortisol samples were obtained throughout the 24-hour period. After the participants left the laboratory, they continued to wear the ambulatory BP monitor throughout the day and night as they carried out their normal activities. They returned to the laboratory 24 hours later.
Questionnaires
Background Questionnaire
The questionnaire was designed to assess the basic demographics of our sample. It included items such as age, gender, ethnicity, marital status, income, and religious activity.
Sleep Quality
Participants completed the Pittsburgh Sleep Quality Inventory, a standard self-report measure that assesses sleep quality, latency, duration, efficiency, and disturbances over the past month. It has been found to have good internal consistency, test-retest reliability, and validity (26). In addition, participants were asked to rate their sleep quality that night as compared with an ordinary night by using a 1- to 5-point scale (1 = much worse than usual; 5 = much better than usual). Because sleep disturbance may account for BP dipping, we treated sleep quality as a covariate.
Physiological Measures
Blood Pressure
BP was measured using ambulatory (portable) BP techniques. The Accutracker II (Suntech Medical Instruments, Raleigh, North Carolina) was used to estimate ambulatory readings of systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR). The Accutraker II was designed specifically for ambulatory assessments and is well validated; the readings correspond with intra-arterial BP assessments during rest, isometric exercise, and bicycle exercise (27,28). Importantly, ambulatory monitors are reportedly accurate in assessing nocturnal BP dipping when compared with intra-arterial BP measurements (29). The monitor was set to randomly take a reading approximately every 20 minutes during the day or waking hours (6AM–10:59 PM) and every hour during the night (11 PM–6 AM).
The Accutraker II uses a number of codes that may signify problems with the estimation of the ambulatory cardiovascular assessment. Based on prior research (30), we deleted readings associated with test codes 2 (weak Korotkoff sounds), 3 (microphone difficulties), and 7 (air leaks). Outliers associated with artifactual readings were also identified using the criteria by Marler and colleagues (31). These criteria included: a) SBP < 70 mm Hg or >250 mm Hg; b) DBP < 45 mm Hg or >150 mm Hg; c) HR < 40 beats/minute or >200 beats/minute; and d) SBP/DBP < [1.065 + (0.00125 x DBP)] or >3.0.
According to the National Heart, Lung, and Blood Institute (NHLBI), the risk of cardiovascular disease begins at 115/75 mm Hg and doubles with each increment of 20/10 mm Hg. Therefore, the NHLBI recommends that patients with an SBP of 120 to 139 mm Hg or a DBP of 80 to 89 mm Hg should be considered as prehypertensive. Classifications used in this study are based on these criteria.
Cortisol
Cortisol was assessed via saliva sampling. This noninvasive method has shown high correlations (r > 0.90) with cortisol from serum and plasma samples (3,32). Consistent with standard salivary sampling procedures, we sampled at standardized times to account for diurnal effects. Samples were obtained by using a standard sampling product (Salivette, Sarstedt, Inc., Newton, North Carolina). Participants were instructed to suck or chew on a cotton roll until it was saturated (very soggy—usually about 2 to 3 minutes, 1 minute minimum). The cotton roll was then placed inside a retainer and then in the centrifuge tube. Samples were obtained at 7AM, 12 noon, 5 PM, 10 PM, and on wakening, before the subjects got out of bed. Participants were instructed to record the exact time of each sample collection.
To minimize any potential contamination, we gave the participants the following instructions. Participants were told not to eat a major meal within 60 minutes before sample collection, to avoid alcohol for 24 hours before sample collection, and to avoid dairy products 30 minutes before sample collection. We also informed them to be careful about acidic or high-sugar foods; ideally, they should rinse their mouths thoroughly with water 10 minutes before giving a sample to minimize the potential for saliva contamination. To avoid potential blood contamination, we also recommended that they not brush their teeth within 3 hours before sample collection.
Saliva samples were stored in a freezer (–20°C) until shipped for assay. Salivary cortisol was measured with a commercial immunoassay with chemiluminescence detection (CLIA, IBL-Hamburg, Germany). The assay has a lower detection limit of 0.1 nmol/L with intra- and interassay coefficients of variations <8%.
Statistical Analysis
The primary aim of this study was to test if changes in salivary cortisol predicted ambulatory BP dipping. To assess cortisol circadian rhythm, we examined area under the curve (AUC), a commonly used method in endrocrinological studies to assess circadian rhythms. We followed published guidelines (33) and used the formula for AUC with respect to ground (AUCG), which represents total hormone concentration. Nocturnal dipping was calculated by means of the change score—i.e., taking the average of the BP readings obtained during the day (6 AM–11 PM) and subtracting the average of the nighttime readings (11 PM–6 AM) (14–16). Thus, higher scores indicate more dipping.
Separate simultaneous regression analyses were used to examine the prediction of diurnal salivary cortisol, the statistical interaction between cortisol and age, and the interaction between cortisol and prehypertensive status for each BP dipping outcome (SBP and DBP dipping). Simultaneous regression was used to determine the extent to which variables predict the outcome (BP dipping) and their relative importance (34). A power analysis was conducted to estimate the sample size needed. Based on the models, we hypothesized that the sample size was approximately 200. Thus, our sample size exceeds this and we have sufficient power to analyze our hypotheses.
Covariate selection was determined by identifying factors known to independently contribute to BP or cortisol that could potentially confound the results. We identified and entered into the model and thus statistically controlled for gender, BMI, age, phase of menstrual cycle, sleep quality, morning cortisol, and daytime measures of the relevant cardiovascular assessments. Complete data across all variables were obtained from 230 of our participants.
| RESULTS |
|---|
|
|
|---|
|
Before testing our primary hypothesis, we examined if our saliva sampling protocol had been followed properly. On inspection, we found that 12 (3.9%) of our 301 participants failed to provide all five saliva samples. Of these, only three (<1%) were missing >1 of 5 samples. Of those with complete data, it is important to know if these samples were taken at appropriate times to assess diurnal variation. Compliance, determined by comparing the instructed sample collection time against the participants recorded time, was calculated as the number of compliant samples divided by the total number of samples. Because the first morning sample was scheduled and taken in the laboratory, these samples were all considered compliant. Consistent with research (35), daytime samples were considered compliant if they were ±60 minutes of the instructed sampling time and waking samples were considered compliant if they were within ±15 minutes of awakening. On inspection, we found that 5.6% of samples did not have a recorded time associated with them and 3% were not taken at the correct times. To be conservative, we assumed that those with no recorded time were not compliant with the time we specified. Therefore, our overall study compliance was 91%.
Does Diurnal Variation Salivary Cortisol Predict BP Dipping?
Results indicated that diurnal variation in cortisol, as measured by AUCG, was a significant predictor of BP dipping.1 The relationship was ß = –0.31, p < .0001 for SBP, and ß = –0.37, p < .0001 for DBP. Thus, the less cortisol changed, the less BP dipped at night. The cortisol AUC also had a larger standardized ß than any of the covariates, including BMI.
Does Prediction of BP Dipping Depend on Age?
Advancing age has been identified in the literature as being associated with decreased dipping in both men and women (36). Consistent with the literature, we found that age did predict dipping for both SBP (ß = –0.18, p = .003) and DBP (ß = 0.14, p = .02). We next tested the interaction between age and cortisol to determine if the association of cortisol and BP dipping differs as a function of age. Regardless of whether we treated age continuously or dichotomously (young = <40 years; older = >40 years), we found no significant interaction effect (age x cortisol) on the prediction of BP dipping. Thus, diurnal cortisol variation predicts nocturnal BP dipping regardless of age.
Does Prediction of BP Dipping Depend on Prehypertensive Status?
Given that much of the literature examines nocturnal BP dipping among hypertensive patients, we examined if the effects seem to differ according to classification of prehypertension. Regardless of whether classification of prehypertensive status was based on clinic or daytime ambulatory BP, prehypertensive status did not predict nocturnal BP dipping. Likewise, there was no significant interaction between prehypertensive status and cortisol for SBP or DBP dipping. Thus, cortisol diurnal variation predicts nocturnal dipping regardless of prehypertensive status.
| DISCUSSION |
|---|
|
|
|---|
Given that prior research has primarily examined BP dipping among hypertensive patients, older adults, or both (16,18,37), it is unclear the extent to which a lack in nocturnal dipping may be health relevant among young healthy adults. Data from Parati and colleagues (38) suggested that lack of nocturnal BP dipping among normotensive young adults may be indicative of future cardiovascular risk. Importantly, evidence from large prospective studies indicated that, for each 5% increment in the dipping ratio (i.e., nocturnal BP/diurnal BP), there is a 20% to 30% increase in cardiovascular morbidity and mortality (20,39,40). Thus, the health relevance of data from young healthy adults should not be dismissed. Nevertheless, longitudinal studies will be necessary to clarify the extent of long-term health significance.
It is important to acknowledge some potential limitations to this study. First, we only sampled over 1 day. Research indicated that there are individual differences in the extent to which peoples diurnal cycles are consistent (41–43). Also, because we did not sample over multiple days, we cannot determine a causal direction. Likewise, we only sampled BP hourly during the night; a more frequent sampling protocol could increase accuracy. Therefore, future research would be wise to assess more frequently over multiple days to draw firm conclusions. Second, our sample population was predominantly white and educated. Research on nocturnal BP dipping indicates significant differences based on race (12,14,44–46) and SES (47,48). Therefore, the extent to which our sample is generalizable is yet to be determined. Third, we relied on self-report to determine compliance with salivary cortisol sampling. Although compliance with our protocol was high, it is possible that self-reported compliance may be overestimated (35). Finally, this was a cross-sectional study using healthy subjects. Prospective studies, including equal distributions of normotensive, prehypertensive, and hypertensive subjects, may help us better understand the long-term health consequences.
Overall, we believe these findings may have important implications. Our data are consistent with models that argue physiologic systems are interdependent. These systems are coordinated and over time can lead to dysregulation. For instance, central corticotropin-releasing hormone can activate both the automatic nervous system and HPA axis (49) and stimulates the release of ß endorphins (50) and, hence, may initially coordinate the patterning. However, it is possible that over time there is difficulty in turning off the cortisol response (51). In addition, reciprocal associations exist between more peripheral physiological processes and central pathways (52). The complexities of these responses and the conditions under which they may be coordinated are currently being investigated (3,53). Thus, these physiological responses, so closely responsive to psychosocial factors including stress, may affect the body in multiple ways that are interdependent. For instance, neuroendocrine rhythms have the potential to modulate the autonomic control of BP, potentially triggering the onset of cardiovascular events. There is also the potential for autonomic control of BP to modulate neuroendocrine rhythms. An integrative understanding of such processes may be important to identify common (potentially modifiable) pathways as well as reconcile inconsistencies in prior research (e.g., protective/damaging effects). Future studies will benefit from examining how these two variables interact in predicting disease outcomes.
We thank Brandon Jones, Shayna Ernhofer, Laura Cummings, Chad Jenson, Adam Howard, Wendy Birmingham, Brian Mead, and Britta Thunnell for their help running participants through the protocol.
| NOTES |
|---|
|
|
|---|
This research was generously supported by Grant R0502042 from the Marchionne Foundation and a grant from the Family Studies Center at Brigham Young University (J.H.-L.).
Received for publication June 5, 2006; revision received January 17, 2007.
DOI:10.1097/PSY.0b013e318050d6cc
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |